Comment on Kridin et al.—Considering both relative and absolute risk differences in infection risk between biologics classes in patients with psoriasis-Reference-Cited by-同舟云学术

Comment on Kridin et al.—Considering both relative and absolute risk differences in infection risk between biologics classes in patients with psoriasis

Published:2023-11-12 Issue: Volume: Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Pham James P.¹²³^ORCID,Jepsen Rebecca¹²,Frew John W.¹²³

Affiliation:

1. Department of Dermatology Liverpool Hospital Liverpool New South Wales Australia

2. Laboratory of Translational Cutaneous Medicine Ingham Institute for Applied Medical Research Liverpool New South Wales Australia

3. School of Clinical Medicine UNSW Medicine and Health Sydney New South Wales Australia

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.19615

Reference7 articles.

1. Evaluating the risk of infections under interleukin 23 and interleukin 17 inhibitors relative to tumour necrosis factor inhibitors – a population‐based study;Kridin K;J Eur Acad Dermatol Venereol,2023

2. Anti‐tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management;Gardam MA;Lancet Infect Dis,2003

3. Interpretation of comorbidity risk in hidradenitis suppurativa: comparing odds ratio and ‘number needed to be exposed’;Pham JP;J Eur Acad Dermatol Venereol,2022

4. Calculating the “number needed to be exposed” with adjustment for confounding variables in epidemiological studies;Bender R;J Clin Epidemiol,2002

5. Psoriasis and the risk of pneumonia: a population‐based study;Kao L‐T;PloS One,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply to: ‘Comment on Kridin et al.—Considering both relative and absolute risk differences in infection risk between biologics classes in patients with psoriasis’;Journal of the European Academy of Dermatology and Venereology;2023-11-14